Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Microbial Rapid Testing Principles Likely To Be Added To PAT Guidance

This article was originally published in The Tan Sheet

Executive Summary

FDA will likely incorporate principles related to rapid microbial testing in its upcoming guidance on process analytical technologies

You may also be interested in...



Isolator Technology: Industry Wants Revised Regulations To Encourage Use

FDA should encourage the use of isolator technology by ensuring an open regulatory environment, committee guests agreed at the Pharmaceutical Science Advisory Committee meeting on Oct. 22

Isolator Technology: Industry Wants Revised Regulations To Encourage Use

FDA should encourage the use of isolator technology by ensuring an open regulatory environment, committee guests agreed at the Pharmaceutical Science Advisory Committee meeting on Oct. 22

Pharmacology/Toxicology Subcmte. Will Advise FDA On Drug Safety Issues

FDA is creating a Pharmacology & Toxicology Subcommittee under its Advisory Committee of Pharmaceutical Science to advise the agency on regulatory issues concerning drug-induced toxicity

Related Content

Topics

UsernamePublicRestriction

Register

PS094037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel